IFNA1 and head and neck squamous cell carcinoma: In addition, our results showed that CD279 mRNA encoding PD1 was elevated in PBMCs from healthy controls and HNSCC patients, but the elevation was more prominent in PBMCs from HNSCC patients treated with IFNα (Fig. 4g).